NCT01207635已完成不适用
Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 试验地点
- 1
- 主要终点
- Number of Patients with Antiproliferative Effects of Arimidex
研究概览
简要总结
The goal of this study is to evaluate antiproliferative effects of Arimidex in ductal lavage fluids of Breast Cancer patients.
Breast cancer is the leading cause of cancer incidence and the second leading cause of cancer mortality in women. Breast duct fluid provide biomarkers to aid in risk assessment of developing breast cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patient must have a history of breast cancer.
- •Patient must be scheduled to receive standard treatment with Arimidex for adjuvant hormonal management.
- •Patient must be willing to undergo a duct lavage.
- •Patient must sign an Informed Consent.
排除标准
- 未提供
结局指标
主要结局
Number of Patients with Antiproliferative Effects of Arimidex
时间窗: Study duration 4 years
Biomarker modulation study on effects of Armimidex in ductal lavage fluid from evaluable epithelial cells specimen.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney DiseaseDiabetic NephropathiesHypertensionNCT01918488University of Southern Denmark80
已完成
2 期
Arimidex Multicenter Trial in Growth Hormone (GH) Deficient BoysHypopituitarismNCT00133354Nemours Children's Clinic53
已完成
早期 1 期
A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of DarolutamideBreast Cancer FemaleNCT03004534Translational Research in Oncology36
已完成
2 期
Efficacy of Dihydroartemisinin for Treating PCOSPolycystic Ovary SyndromeNCT06417099Shanghai Zhongshan Hospital30
已完成
不适用
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast CancerAdvanced Breast CancerNCT00562458AstraZeneca200